UDP-glucuronosyltransferase 2B15is anenzymethat in humans is encoded by theUGT2B15gene.[5][6]
The UGTs are of major importance in the conjugation and subsequent elimination of potentially toxicxenobioticsand endogenous compounds. UGT2B8 demonstrates reactivity withestriol.SeeUGT2B4(MIM 600067).[supplied by OMIM][6]
^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
^Monaghan G, Clarke DJ, Povey S, See CG, Boxer M, Burchell B (Feb 1995). "Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13".Genomics.23(2): 496–9.doi:10.1006/geno.1994.1531.PMID7835904.
Coffman BL, Tephly TR, Irshaid YM, et al. (1990). "Characterization and primary sequence of a human hepatic microsomal estriol UDPglucuronosyltransferase".Arch. Biochem. Biophys.281(1): 170–5.doi:10.1016/0003-9861(90)90428-2.PMID2116769.
Irshaid YM, Tephly TR (1987). "Isolation and purification of two human liver UDP-glucuronosyltransferases".Mol. Pharmacol.31(1): 27–34.PMID3100939.
Green MD, Clarke DJ, Oturu EM, et al. (1995). "Cloning and expression of a rat liver phenobarbital-inducible UDP-glucuronosyltransferase (2B12) with specificity for monoterpenoid alcohols".Arch. Biochem. Biophys.322(2): 460–8.doi:10.1006/abbi.1995.1489.PMID7574722.
Green MD, Oturu EM, Tephly TR (1995). "Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates".Drug Metab. Dispos.22(5): 799–805.PMID7835232.
Chen F, Ritter JK, Wang MG, et al. (1993). "Characterization of a cloned human dihydrotestosterone/androstanediol UDP-glucuronosyltransferase and its comparison to other steroid isoforms".Biochemistry.32(40): 10648–57.doi:10.1021/bi00091a015.PMID8399210.
Lévesque E, Beaulieu M, Green MD, et al. (1997). "Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene".Pharmacogenetics.7(4): 317–25.doi:10.1097/00008571-199708000-00007.PMID9295060.
Tchernof A, Lévesque E, Beaulieu M, et al. (1999). "Expression of the androgen metabolizing enzyme UGT2B15 in adipose tissue and relative expression measurement using a competitive RT-PCR method".Clin. Endocrinol.50(5): 637–42.doi:10.1046/j.1365-2265.1999.00709.x.PMID10468930.S2CID43030627.
Gsur A, Preyer M, Haidinger G, et al. (2002). "A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk".Cancer Epidemiol. Biomarkers Prev.11(5): 497–8.PMID12010866.
Court MH, Duan SX, Guillemette C, et al. (2003). "Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9".Drug Metab. Dispos.30(11): 1257–65.doi:10.1124/dmd.30.11.1257.PMID12386133.
Kanaya J, Takashima M, Koh E, Namiki M (2003). "Androgen-independent growth in LNCaP cell lines and steroid uridine diphosphate-glucuronosyltransferase expression".Asian J. Androl.5(1): 9–13.PMID12646996.
Tomboc M, Witchel SF (2003). "Frequencies of the D85 and Y85 variants of UGT2B15 in children and adolescent girls with hyperandrogenism".J. Pediatr. Endocrinol. Metab.16(5): 719–26.doi:10.1515/jpem.2003.16.5.719.PMID12880121.S2CID32217321.
Court MH, Hao Q, Krishnaswamy S, et al. (2005). "UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver".J. Pharmacol. Exp. Ther.310(2): 656–65.doi:10.1124/jpet.104.067660.PMID15044558.S2CID5946464.
Toide K, Umeda S, Yamazaki H, et al. (2005). "A major genotype in UDP-glucuronosyltransferase 2B15".Drug Metab. Pharmacokinet.17(2): 164–6.doi:10.2133/dmpk.17.164.PMID15618667.
Chouinard S, Pelletier G, Bélanger A, Barbier O (2005). "Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium".Endocr. Res.30(4): 717–25.doi:10.1081/ERC-200044014.PMID15666817.S2CID10971899.